|
 The Association of Clinical Microbiologists Spring 2010 Scientific Meeting will be held on Tuesday 11th May 2010 at the Scottish Exhibition and Conference Centre in Glasgow as part of the Association for Clinical Biochemistry’s Focus 2010 meeting. The title of the meeting is Respiratory Pathogens, with presentations from eminent speakers on topics including mycoplasma, legionella, tuberculosis, pneumocystis, swine flu, ICU infections and many more. There will also be poster sessions as part of the ACB’s Focus programme and the opportunity to attend the Roche Diagnostics Award Lecture, “Adding Value to Clinical Biochemistry”, given by Dr Graham Beastall. Please see the Programme for full details.
You can register on-line (kindly provided by the Infectious Disease Research Network) or by contacting the ACM Joint Meetings Organiser Dr Deborah Gascoyne-Binzi (details on the programme). Registration for this one-day meeting is discounted for ACM and IBMS members, and is free for delegates of Focus 2010. We hope that there’s something in the programme for everyone with an interest in respiratory infections, and look forward to seeing you there.
|
|
Enhance your EBLM skills at the workshop organized by the ACB Education
and Scientific Committees. Places are limited and there is a charge of £20 to attend the workshop.
The workshop aims to help participants develop EBLM skills and will include
the following sessions:
• Formulating the Question
• Acquiring the Evidence
• Appraising the Evidence
Working in groups of 7 or 8, the workshop will apply this approach to a
number of topical issues under the guidance of a mentor, with the aim of
developing a publication on the topic during the next 3-6 months.
|
|
 Abbott Diagnostics will host a session on the Wednesday on kidney disease, something that continues to exercise the medical fraternity. With between 6 and 20% of all acute hospital admissions and 30% of all ITU patients developing some degree of acute kidney injury and an estimated 10% of the ageing population progressing to some form of chronic kidney disease, renal disease continues to present a major challenge. During this session, the roles of both established and emerging renal biomarkers and how they contribute to improving patient management will be reviewed.
 On the Thursday Siemens Healthcare Diagnostics will host a session on POCT for cardiac markers reporting a multicentre study. This will deal with the future of chest pain diagnosis including both diagnosis and rapid stratification of ACS patients as well as touching on the next generation of assay sensitivity which will be a challenge to both clinicians and the laboratory.
|
